BIOCRYST PHARMACEUTICA

BioCryst Announces Approval of ORLADEYO® (berotralstat) by the National Administration of Drugs, Foods, and Medical Devices (ANMAT) in Argentina

29 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire

BioCryst to Present at Upcoming Investor Conferences

21 11月 2023 16:01:44 条件 Nasdaq GlobeNewswire

BioCryst Launches ORLADEYO® (berotralstat) in Spain

21 11月 2023 07:00:13 条件 Nasdaq GlobeNewswire

BioCryst Presents New Real-world Data Showing Reduced Attack Rates in Patients with HAE with Normal C1-inhibitor Following Long-term Treatment with ORLADEYO® (berotralstat)

10 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 11月 2023 16:01:28 条件 Nasdaq GlobeNewswire

BioCryst R&D Day Highlights New Diversified Pipeline of First-in-Class/Best-in-Class Therapies with Five Programs Expected in Clinical Development in Next 24 Months

03 11月 2023 12:03:00 条件 Nasdaq GlobeNewswire

BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside’s Proprietary SCS Microinjector®

03 11月 2023 12:00:00 条件 Nasdaq GlobeNewswire

BioCryst Reports Third Quarter 2023 Financial Results and Provides Business Update

02 11月 2023 07:00:55 条件 Nasdaq GlobeNewswire

BioCryst to Present New ORLADEYO® (berotralstat) Data at Annual Scientific Meeting of American College of Allergy, Asthma & Immunology

27 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire

BioCryst Begins Enrollment in Proof-of-Concept Trial to Confirm Safe, Effective, Once-daily Dose of Oral Factor D Inhibitor, BCX10013

26 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire

BioCryst to Host R&D Day on November 3

20 10月 2023 07:00:08 条件 Nasdaq GlobeNewswire

BioCryst to Report Third Quarter 2023 Financial Results on November 2

19 10月 2023 07:00:16 条件 Nasdaq GlobeNewswire

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 10月 2023 07:00:41 条件 Nasdaq GlobeNewswire

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 9月 2023 07:00:46 条件 Nasdaq GlobeNewswire

BioCryst to Present at Upcoming Investor Conferences

23 8月 2023 16:01:54 条件 Nasdaq GlobeNewswire

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 8月 2023 16:01:28 条件 Nasdaq GlobeNewswire

BioCryst Reports Second Quarter 2023 Financial Results and Provides Business Update

03 8月 2023 07:00:58 条件 Nasdaq GlobeNewswire

BioCryst to Report Second Quarter 2023 Financial Results on August 3

20 7月 2023 07:00:37 条件 Nasdaq GlobeNewswire

BioCryst Selects Er-Kim Pharmaceuticals as Commercial Partner for ORLADEYO® (berotralstat) in Turkey

19 7月 2023 07:00:00 条件 Nasdaq GlobeNewswire

BioCryst to Participate in the 2023 US HAEA National Summit

17 7月 2023 07:00:00 条件 Nasdaq GlobeNewswire